Once-daily insulin glargine requires a significantly lower dose than insulin detemir twice daily to achieve good glycaemic control in patients with type 2 diabetes failing oral therapy Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Swinnen, SGH
  • Dain, MP
  • Aronson, R
  • Roberts, D
  • Davies, M
  • Gerstein, Hertzel Chaim
  • Pfeiffer, AFH
  • DeVries, JH
  • Hoekstra, JBL
  • Holleman, F

publication date

  • September 1, 2009